Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Carisma Therapeutics Inc. (CARM) had Operating Cash Flow per Share of $-0.24 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$3.73M |
|
$-9.27M |
|
-- |
|
$3.73M |
|
$13.06M |
|
$-9.33M |
|
$0.07M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
$-9.33M |
|
$-8.67M |
|
41.77M |
|
41.77M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$13.95M |
|
-- |
|
$2.00M |
|
$15.95M |
|
$10.45M |
|
-- |
|
$42.17M |
|
$52.62M |
|
$-36.66M |
|
$-36.66M |
|
$-36.66M |
|
41.79M |
|
| Cash Flow Statement Financials | |
$-10.07M |
|
$0.52M |
|
$-0.63M |
|
$17.91M |
|
$7.74M |
|
$-10.17M |
|
$0.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.34 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
100.00% |
|
-250.31% |
|
-250.31% |
|
-- |
|
-248.48% |
|
-248.48% |
|
$-9.54M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
-- |
|
-- |
|
-- |
|
25.27% |
|
25.27% |
|
-58.08% |
|
25.27% |
|
$-0.88 |
|
$-0.23 |
|
|
Operating Cash Flow per Share |
$-0.24 |